Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats

Research areas:
Year:
2016
Type of Publication:
Article
Journal:
Acta Physiologica
Volume:
217
Number:
4
Pages:
287-299
Note:
cited By 40
DOI:
10.1111/apha.12698
Hits: 102